Towards first-in-class siRNA therapeutics for adrenal targets

• Forschungsstelle: INNOSUISSE
• Projektnummer: 134.630 IP-LS
• Projekttitel Englisch: Towards first-in-class siRNA therapeutics for adrenal targets

Schlüsselwörter (Englisch)

Life sciences, Pharmaceuticals

Abstract (Englisch)

We aim to develop first-in-class siRNA drug candidates for adrenal targets using Procavea's proprietary, protein-based delivery platform. The pre-clinical data generated will serve to further validate the technology platform, bringing it closer to commercialization.